Recent uptick might appease OptiNose, Inc. (NASDAQ:OPTN) institutional owners after losing 50% over the past year [Yahoo! Finance]
OptiNose, Inc. (NASDAQ: OPTN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million [Yahoo! Finance]
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
OptiNose (NASDAQ:OPTN) shareholders have endured a 87% loss from investing in the stock five years ago [Yahoo! Finance]